Pharmaceutical Supply – Hydrochlorothiazide Tablets

The contract requires the supply of 2,000 bottles of hydrochlorothiazide tablets, USP, as a commercial off-the-shelf item, with strict compliance regarding packaging and labeling standards to meet regulatory and operational requirements. The procurement is structured as a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with the place of performance designated as FPO, ZIP 96678, indicating delivery to a military location, likely overseas or in a remote operational theater. The solicitation was posted on April 30, 2026, and responses are due by May 6, 2026, with a NAICS code of 325412 confirming the pharmaceutical manufacturing classification. All units must be delivered in fully compliant, ready-to-use packaging that adheres to applicable U.S. pharmacopeial standards and defense logistical protocols, ensuring the product is suitable for immediate distribution to military medical facilities.